Back to URGN
Elmind Capital, LP URGN Position History
UroGen Pharma Ltd. • Healthcare
Quarters held
4
Latest value
$20M
Q3 2026
Peak value
$20M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.3M |
| Q1 2026 | $4M |
| Q2 2026 | $4.4M |
| Q3 2026 | $20M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $20M | 491.1K | — | — |
| Q2 2026 | $4.4M | 120.0K | — | — |
| Q1 2026 | $4M | 220.0K | — | — |
| Q4 2025 | $2.3M | 100.0K | — | — |
Other funds holding URGN
$184.6M
$167.2M
$106.4M
$93.6M
$91.7M